“Emerging infections, the re-emergence of infectious diseases previously considered to be under control, and the alarming trend of antibiotic resistance….require.

Slides:



Advertisements
Similar presentations
ANTIBIOTICS. The selection of antibiotic therapy for an infection requires a knowledge of: 1The infecting organism, including the pathogen most likely.
Advertisements

Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Animal Model PK/PD: A Tool for Drug Development
Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
The Increasing Public Health Exigency of Antimicrobial Resistance Alfred DeMaria, Jr., M.D. Massachusetts Department of Public Health.
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
What intervention on the use or dosing of antibiotics work to decrease resistance? Jan. 18, 2007 Sung-Ching Pan.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Antimicrobials 3: Resistance Dr Fiona Walsh. Objectives of lecture Genetics of resistance Mechanisms of resistance Current and future problems.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
PHL 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
MECHANISMS OF ACTION OF ANTIBIOTICS. BACTERIOSTATIC AGENTS Sulfonamides Drugs inhibiting protein synthesis except aminoglycosides (macrolides, chloramphenicol,
CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.
Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
ANTIMICROBIAL RESISTANCE Edith Blondel-Hill MD,FRCP Medical Microbiologist/Infectious Diseases Specialist Medical Director Interior Health Antimicrobial.
CHAPTER 20 ANTIBIOTIC RESISTANCE
Mechanisms of antimicrobial action directed against the bacterial cell wall and corresponding resistance mechanisms M-4 Advanced Therapeutics Course.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
Antimicrobial Medications (Part I) Supplemental instruction Designed by Pyeongsug Kim ©2010 Fall 2010 For Dr. Wright’s Bio 7/27.
Antibiotic Resistance The Miracle Revoked? Wilson “Bill” Muse 10/29/2009.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
The Genetics of Antibiotic Resistance Research Theme: Infectious Diseases Jason Kuehner March 5, 2007.
Batterjee Medical College. Dr. Manal El Said Department Head of Microbiology Antimicrobial Drugs: Mechanism of Action.
Antibiotic Resistance in Microbes A few microbes to be concerned about How some antibiotics and Antimicrobials work Resistance mechanisms Some factors.
Antimicrobial Drugs.
Chapter 15: Antimicrobial Drugs ChemotherapyThe use of drugs to treat a disease Antimicrobial drugsInterfere with the growth of microbes within a host.
1 ANTIMICROBIAL THERAPY CHAPTER Chemotherapeutic Agents Antibiotics: bacteriocidal vs bacteriostatic Synthetic Drugs vs natural product.
Clinical implications of tissue concentrations Ursula Theuretzbacher Center for Anti-Infective Agents, Vienna, Austria Clinical Issues of PK/PD, ECC, Firenze.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Supplemental testing methods
Antibiotics I.. Consequences of inappropriate antibiotic therapy Inappropriate antibiotic therapy can lead to increases in:Inappropriate antibiotic therapy.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Treatment of Infectious Diseases. ›Drugs used to treat bacterial diseases are grouped into categories based on their modes of action Treatment of Bacterial.
Antibiotics (anti-microbials)
PRINCIPLES OF ANTIBIOTIC THERAPY
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
Dr. Abdulaziz Bin Saeedan Department of Pharmacology College of Pharmacy MACROLIDES ANTIBIOTICS.
Protein Synthesis Inhibitors
Drugs and Microbes.
Antibiotic Resistance
Lecture 1 Antimicrobial drugs.
By :Lecturer Nabeel Ahmed Al anbagi
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
General considerations of antimicrobial agents (抗微生物药物概论)
R. Leclercq  Clinical Microbiology and Infection 
Simone M. Shurland, Ph.D., Division of Anti-Infective Products
Antibiotics in 2005: Which one do we need to use and when ?
Drugs that Inhibit Cell wall synthesis
Chapter 20 Antibacterial Agents
Antibiotic Resistance
D.E. Low  Clinical Microbiology and Infection 
Introduction to antibacterial drugs
Principles of Antimicrobial Therapy
Drug Resistance Bacteria are considered resistant to an antibiotic if the maximal level of that antibiotic that can be tolerated by the host does not halt.
Chemotherapeutic Medicine
A. Fajardo, J.F. Linares, J.L. Martínez 
M.R. Jacobs  Clinical Microbiology and Infection 
Infection services in the intensive care unit
Other β-lactam A. Carbapenems:
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Antimicrobial resistance
Principles of Antimicrobial Therapy
Introduction to Microbiology
Figure 1 Infection and resistance in urological practice
Presentation transcript:

“Emerging infections, the re-emergence of infectious diseases previously considered to be under control, and the alarming trend of antibiotic resistance….require an immediate and appropriate response.” Dr. Gail Cassell, Past President, American Society of Microbiology, May 1994

Mechanisms of Resistance Decreased membrane permeability ( Gram negatives only; also need another mechanism to be significant) Enzymatic Inactivation of Antimicrobial Target Site Alteration or Bypass Efflux Pumps

Mechanisms Of Resistance Expressed In Military Terms Armour Antiballistic Missiles Diversion & Camouflage Hand to Hand Combat

Altered Membrane Permeability  -Lactam Antibiotic Porin Outer Membrane Protein Inner Membrane

Penicillins Adapted from Denver LA, Dermody TS. Arch Intern Med  -LACTAMASE HYDROLYSIS Cephalosporins

Action of Aminoglycoside - Inactivating Enzymes OH OH OH I I I -OH  HO-P-O-P-O-P-O-adenosine II II II O O O OH OH OH I I I -O-P-OH  HO-P-O-P-O-adenoside II II II O O O phosphorylation OH OH OH I I I -O-P-O-adenosine  OH-P-O-P-OH II II II O O O adenylation -NH  CH -C-S-coenzyme A II O 2 3 -NH -C-CH  HS-coenzyme A II O acetylation 3

Target Site Alteration  -Lactam Antibiotic Inner Membrane Porin Altered Penicillin Binding Protein Normal Penicillin Binding Protein

Transmembrane Efflux Pumps: Antimicrobials Tetracyclines Fluoroquinolones Macrolides

Antibiotic Resistance is a function of: Genetic variability and environmental stimuli

S. pneumoniae Resistance and Antibiotic Use * S. pneumoniae susceptibilities and antibiotic use were studied in 37 counties in seven US states Antibiotic use: defined as daily doses per capita from IMS America data Counties with greater use of ß - lactams and macrolides had significantly higher rates of S. pneumoniae resistance to those agents * Schwartz et al. ICAAC 1998

Antimicrobial agent Penicillins Cephalosporins Aminoglycoside Imipenem Ciprofloxacin No. of studies No. of infections Development of Resistance 9 % 13 % 5 % 12 % Therapeutic failures 5 % 4 % 11 % 3 % 4 % Summary of Resistance Development During Antibiotic Treatment

‘82 ‘84 ’86 ‘88 ’90 ‘92 ‘94 YEAR 20,000 16,000 12,000 8,000 4,000 0 Number of Organ Transplants, United States,

Penicillin-resistant S. pneumoniae Canadian isolates

Clinical Implications: PRSP Intermediate R: can overcome with high doses of usual PO drugs, but continue to select for higher levels of resistance High Level R: Usual PO drugs fail, need resp FQ, telithromycin or IV pen

Macrolide-resistant S. pneumoniae Canadian isolates

PK/PD Variables in Selection of Resistance Potency: varies with class of antimicrobial Primarily determined within a drug class by level of free drug in serum Low potency favors selection of resistant isolates

Clarithromycin Azithromycin Selective Window MAC MIC Concentration ( ug/ml ) Weeks Longer half-life antibiotics may create a greater window of opportunity for the development of resistance Guggenbichler JP, Kastner H Infect Med 14 Suppl C: (1997) Effect of Elimination Kinetics on Bacterial Resistance

“ I want you to take one of these with water every four years ”

Handwashing The most important method for preventing the spread of infections ~70% of PRSP in US belong to seven clonal groups Antimicrobial handwashing agents - alcohol based handrinses Wash hands before and after: - all patient contact - contact with infective material

“….we have too many illusions that we can… govern… the microbes that remain our competitors of last resort for dominion of the planet.” Lederberg J. JAMA 1988;260:684-5.

“….Pitted against microbial genes, we have mainly our wits.” Joshua Lederberg, Ph.D. Nobel Laureate JAMA 1996;276:418